Hemolysis in Patients Supported with Durable, Long-Term Left Ventricular Assist Device Therapy Jason N. Katz, MD,MHS; Brian C. Jensen, MD; Patricia P.
Presentations: Quantifying the impact of adverse events on HRQOL early after implant Patient selection and estimation of prognosis using health status.
J138-0711 Contemporary Outcomes With the HeartMate II ® LVAS David J. Farrar, PhD Vice President, Research and Scientific Affairs Thoratec Corporation.
